Treatment of osteoporosis after alendronate or risedronate.

about

Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene.

P2860

Q40437923-A10D4B92-126D-4C58-A817-8DD796B0BFD1 Q45341149-E7E0C34F-5BF6-494D-B5B3-DFE4354BBD61

P2860

Treatment of osteoporosis after alendronate or risedronate.

Item

http://www.wikidata.org/entity/Q38599682

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Treatment of osteoporosis after alendronate or risedronate.

@en

type

Item

label

Treatment of osteoporosis after alendronate or risedronate.

@en

prefLabel

Treatment of osteoporosis after alendronate or risedronate.

@en

P1476

Treatment of osteoporosis after alendronate or risedronate.

@en

P2093

P Eiken

http://www.w3.org/2001/XMLSchema#string

P Vestergaard

http://www.w3.org/2001/XMLSchema#string

P2860

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.

Osteoporosis prevention, diagnosis, and therapy.

Clinician's Guide to Prevention and Treatment of Osteoporosis

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.

P2888

s00198-015-3334-4

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-015-3334-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043452342

http://www.w3.org/2001/XMLSchema#string

P698

26438307

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Treatment of osteoporosis after alendronate or risedronate.

about

P2860

P2860

Treatment of osteoporosis after alendronate or risedronate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921